GGrantIndex
Sort

16,179 grants matching malaria

GETTING TO ZERO: SATELLITE INFORMED SYSTEM TO SUPPORT ELIMINATION OF MALARIA IN THE AMERICAS (SISTEMA)

$1,049,979
Duke University · · FY2022 · National Aeronautics and Space Administration

COBRE for Perinatal Biology

$1,048,274
Sunil K Shaw · Women And Infants Hospital-Rhode Island · P30 · FY2016 · GM

Malaria Vaccine Trials in Mali

$1,047,695
Christopher V. Plowe · University Of Maryland Baltimore · U19 · FY2006 · AI

An Oral Ultra Long-Acting Ivermectin for Malaria Elimination

$1,047,601
Andrew Martin Bellinger · Lyndra Therapeutics, Inc. · R44 · FY2017 · TR

CMV Immunotherapeutic Vaccine

$1,047,535
Ronald B Moss · Vical, Inc. · R44 · FY2007 · AI

Institutional Research Collaboration between the Liverpool School of Tropical Medicine and the Centers for Department of Health and Human Services Centers for Disease Control and Prevention

$1,047,183
Feiko Olaf Ter Kuile · Tmliverpool School Of Tropical Medicine · U01 · FY2016 · GH

CMV Immunotherapeutic Vaccine

$1,047,158
David C. Kaslow · Vical, Inc. · R44 · FY2006 · AI

Malaria vectorial system and vector control in Southeast Asia

$1,046,700
Jetsumon Prachumsri · University Of South Florida · U19 · FY2021 · AI

Southeast Asia Malaria Research Center

$1,046,700
Liwang Cui · University Of South Florida · U19 · FY2021 · AI

Assay Work for Malaria Vaccines - VTEU

$1,046,584
Emmanuel B Walter · Duke University · N01 · FY2020 · AI

Optimizing the dose of tafenoquine for the radical cure of Plasmodium vivax malaria in Southeast Asia

$1,045,386
Cindy S Chu · University Of Oxford · U01 · FY2024 · AI

The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition

$1,045,227
Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Development of Antimalarial Preclinical Candidates

$1,044,090
R Kiplin Guy · St. Jude Children'S Research Hospital · U01 · FY2008 · AI

CMV Immunotherapeutic Vaccine

$1,042,445
Vical, Inc. · R44 · FY2005 · AI

Epidemiology Project

$1,041,161
Moses Robert Kamya · University Of California, San Francisco · U19 · FY2023 · AI

Malaria Parasite Sexual Development, Drug Resistance, and Evolution

$1,040,572
Xinzhuan Su · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Malaria Vaccine Trials in Mali

$1,039,899
Christopher V. Plowe · University Of Maryland Baltimore · U19 · FY2008 · AI

Epidemiology Project

$1,039,072
Moses Robert Kamya · University Of California, San Francisco · U19 · FY2022 · AI

Enhanced collaboration between US NIH and WHO on biomedical research

$1,038,805
Hans Troedsson · World Health Organization · U01 · FY2016 · AI

Lead Identification to Clinical Candidate Selection: Drugs for Chagas Disease

$1,038,431
James H. McKerrow · University Of California, San Francisco · R01 · FY2010 · AI

Accelerating discovery of an efficacious Plasmodium vivax multivalent multi-stage vaccine

$1,036,232
John Adams · University Of South Florida · U01 · FY2021 · AI

Telomere Structure In Drosophila

$1,035,844
James M Mason · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES

Malaria Parasite Ligands And Host Cell Receptors

$1,033,057
Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE

$1,032,586
Thomas Meek · Texas A&M Agrilife Research · R01 · FY2018 · AI

The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition

$1,031,803
Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI